ChristopherCarrollSmith

ITCI bullish call activity and insider buying

看多
NASDAQ:ITCI   Intra-Cellular Therapies Inc.
ITCI is moving mostly horizontally lately, and there's definite room for downside to its channel bottom around 10.40, so this is a risky play. However, a large stock purchase a couple days ago by one of the board of directors triggered a large volume of bullish option activity. Possibly the director purchased stock in anticipation of forthcoming clinical trial results that he expects to be positive. Watch this one closely and look for an opportunity to buy nearer the channel bottom. Alternatively, wait for upside channel breakout.

ITCI has generally poor analyst ratings and negative earnings. However, it's made progress toward profitability and generally delivered earnings beats in recent quarters. It next reports on August 6.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。